BRIT1 regulates early DNA damage response, chromosomal integrity, and cancer

Cancer Cell

Volumn 10, Issue 2, 2006, Pages 145-157

  Rai, Rekha ^a   Dai, Hui ^a   Multani, Asha S ^a   Li, Kaiyi ^b   Chin, Koei ^c   Gray, Joe ^c   Lahad, John P ^a   Liang, Jiyong ^a   Mills, Gordon B ^a   Meric Bernstam, Funda ^a   Lin, Shiaw Yih ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

DNA

Indexed keywords

ATM PROTEIN; ATR PROTEIN; BRIT1 PROTEIN; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR 53BP1; TRANSCRIPTION FACTOR MDC1; TRANSCRIPTION FACTOR NBS1; TRANSCRIPTION FACTOR RPA; UNCLASSIFIED DRUG;

ARTICLE; CANCER; CHROMOSOME ABERRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DAMAGE; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; IRRADIATION; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TRANSCRIPTION INITIATION; TUMOR SUPPRESSOR GENE;

EID: 33746857684     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2006.07.002     Document Type: Article

References (73)

1. Alderton G.K., Galbiati L., Griffith E., Surinya K.H., Neitzel H., Jackson A.P., Jeggo P.A., and O'Driscoll M. Regulation of mitotic entry by microcephalin and its overlap with ATR signaling. Nature Cell Biol. 8 (2006) 725-733
2. Bakkenist C.J., and Kastan M.B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421 (2003) 499-506
3. Balajee A.S., and Geard C.R. Replication protein A and r-H2AX foci assembly is triggered by cellular response to DNA double-strand breaks. Exp. Cell Res. 300 (2004) 320-334
4. Barlow C., Eckhaus M.A., Schaffer A.A., and Wynshaw-Boris A. Atm haploinsufficiency results in increased sensitivity to sublethal doses of ionizing radiation in mice. Nat. Genet. 21 (1999) 359-360
5. Bartkova J., Horejsi Z., Koed K., Kramer A., Fort F., Zieger K., Guldberg P., Sehested M., Nesland J.M., Lukas C., et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434 (2005) 864-870
6. Bassing C.H., Suh H., Ferguson D.O., Chua K.F., Manis J., Eckersdorff M., Gleason M., Bronson R., Lee C., and Alt F.W. Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors. Cell 114 (2003) 359-370
7. Bookstein R. Tumor suppressor genes in prostate cancer. In: Chung L.W., Isaacs W.B., and Simons J.W. (Eds). Prostate Cancer: Biology, Genetics, and the New Therapeutics (2001), Humana Press, Totowa, NJ 61-93
8. Budzowska M., Jaspers I., Essers J., de Waard H., van Drunen E., Hanada K., Beverloo B., Hendriks R.W., de Klein A., Kanaar R., et al. Mutation of the mouse Rad17 gene leads to embryonic lethality and reveals a role in DNA damage-dependent recombination. EMBO J. 23 (2004) 3548-3558
9. Carney J.P., Maser R.S., Olivares H., Davis E.M., Le Beau M., Yates III J.R., Hays L., Morgan W.F., and Petrini J.H. The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: Linkage of double-strand break repair to the cellular DNA damage response. Cell 93 (1998) 477-486
10. Casper A.M., Nghiem P., Arlt M.F., and Glover T.W. ATR regulates fragile site stability. Cell 111 (2002) 779-789
11. Celeste A., Petersen S., Romanienko P.J., Fernandez-Capetillo O., Chen H.T., Sedelnikova O.A., Reina-San-Martin B., Coppola V., Meffre E., Difilippantonio M.J., et al. Genomic instability in mice lacking histone H2AX. Science 296 (2002) 922-927
12. Celeste A., Difilippantonio S., Difilippantonio M.J., Fernandez-Capetillo O., Pilch D.R., and Sedelnikova O.A. H2AX haploinsufficiency modifies genomic stability and tumor susceptibility. Cell 114 (2003) 371-383
13. Chan K., Lee J., Guan X., Fan S., and Ng I. High-density allelotyping of chromosome 8p in hepatocellular carcinoma and clinicopathologic correlation. Cancer 94 (2002) 3179-3185
14. DeMarzo A.M., Nelson W.G., Isaacs W.B., and Epstein J.I. Pathological and molecular aspects of prostate cancer. Lancet 361 (2003) 955-964
15. Difilippantonio S., Celeste A., Fernandez-Capetillo O., Chen H.T., Reina San Martin B., Van Laethem F., Yang Y.P., Petukhova G.V., Eckhaus M., Feigenbaum L., et al. Role of Nbs1 in the activation of the Atm kinase revealed in humanized mouse models. Nat. Cell Biol. 7 (2005) 675-685
16. DiTullio Jr. R.A., Mochan T.A., Venere M., Bartkova J., Sehested M., Bartek J., and Halazonetis T.D. 53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer. Nat. Cell Biol. 4 (2002) 998-1002
17. Eyfjord J.E., and Bodvarsdottir S.K. Genomic instability and cancer: Networks involved in response to DNA damage. Mutat. Res. 592 (2005) 18-28
18. Fang Y., Tsao C.C., Goodman B.K., Furumai R., Tirado C.A., Abraham R.T., and Wang X.F. ATR functions as a gene dosage-dependent tumor suppressor on a mismatch repair-deficient background. EMBO J. 23 (2004) 3164-3174
19. Goldberg M., Stucki M., Falck J., D'Amours D., Rahman D., Pappin D., Bartek J., and Jackson S.P. MDC1 is required for the intra-S-phase DNA damage checkpoint. Nature 421 (2003) 952-956
20. Gollin S.M. Mechanisms leading to chromosomal instability. Semin. Cancer Biol. 15 (2005) 33-42
21. Gorgoulis V.G., Vassiliou L.V., Karakaidos P., Zacharatos P., Kotsinas A., Liloglou T., Venere M., Ditullio Jr. R.A., Kastrinakis N.G., Levy B., et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434 (2005) 907-913
22. Jackson A.P., Eastwood H., Bell S.M., Adu J., Toomes C., Carr J.M., Roberts E., Hampshire D.J., Crow Y.J., Mighell A.J., et al. Identification of microcephalin, a protein implicated in determining the size of the human brain. Am. J. Hum. Genet. 71 (2002) 136-142
23. Kang J., Ferguson D., Song H., Bassing C., Eckersdorff M., Alt F.W., and Xu Y. Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression. Mol. Cell. Biol. 25 (2005) 661-670
24. Kastan M.B., and Bartek J. Cell-cycle checkpoints and cancer. Nature 432 (2004) 316-323
25. Lam M.H., Liu Q., Elledge S.J., and Rosen J.M. Chk1 is haploinsufficient for multiple functions critical to tumor suppression. Cancer Cell 6 (2004) 45-59
26. Lassus H., Laitinen M., Anttonen M., Heikinheimo M., Aaltonen L., Ritvos O., and Butzow R. Comparison of serous and mucinous ovarian carcinomas: distinct pattern of allelic loss at distal 8p and expression of transcription factor GATA-4. Lab. Invest. 81 (2001) 517-526
27. Lee J.H., and Paull T.T. ATM activation by DNA double strand breaks through the Mre11-Rad50-Nbs1 complex. Science 308 (2005) 551-554
28. Lin S.-Y., and Elledge S.J. Multiple tumor suppressor pathways negatively regulate telomerase. Cell 113 (2003) 881-889
29. Lin S.-Y., Rai R., Li K., Xu Z.-X., and Elledge S.J. BRIT1/MCPH1 is a DNA damage responsive protein that regulates the Brca1-Chk1 pathway, implicating checkpoint dysfunction in microcephaly. Proc. Natl. Acad. Sci. USA 102 (2005) 15105-15109
30. Liu J.S., Kuo S.R., Tin X., Beerman T.A., and Melendy T. DNA damage by the enediyne C-1027 results in the inhibition of DNA replication by loss of replication protein A function and activation of DNA-dependent protein kinase. Biochemistry 40 (2001) 14661-14668
31. Lou Z., Minter-Dykhouse K., Wu X., and Chen J. MDC1 is coupled to activated CHK2 in mammalian DNA damage response pathways. Nature 421 (2003) 957-961
32. Miller B., Wang D., Krahe R., and Wright F. Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions. Am. J. Hum. Genet. 73 (2003) 748-767
33. Mills K.D., Ferguson D.O., and Alt F.W. The role of DNA breaks in genomic instability and tumorigenesis. Immunol. Rev. 194 (2003) 77-95
34. Motoyama N., and Naka K. DNA damage tumor suppressor genes and genomic instability. Curr. Opin. Genet. Dev. 14 (2004) 11-16
35. Nyberg K.A., Michelson R.J., Putnam C.W., and Weinert T.A. Toward maintaining the genome: DNA damage and replication checkpoints. Annu. Rev. Genet. 36 (2002) 617-656
36. Osborn A., Elledge S., and Zou L. Checking on the fork: the DNA-replication stress-response pathway. Trends Cell Biol. 12 (2002) 509-516
37. Paull T.T., Rogakou E.P., Yamazaki V., Kirchgessner C.U., Gellert M., and Bonner W.M. A critical role of histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr. Biol. 10 (2000) 886-895
38. Peng A., and Chen P.L. NFBD1/Mdc1 mediates ATR-dependent DNA damage response. Cancer Res. 65 (2005) 1158-1163
39. Petrini J.H., and Stracker T.H. The cellular response to DNA double-strand breaks: defining the sensors and mediators. Trends Cell Biol. 13 (2003) 458-462
40. Pinkel D., Segraves R., Sudar D., Clark S., Poole I., Kowbel D., Collins C., Kuo W.L., Chen C., Zhai Y., et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat. Genet. 20 (1998) 207-211
41. Pribill I., Speiser P., Leary J., Leodolter S., Hacker N., Friedlander M., Birnbaum D., Zeillinger R., and Krainer M. High frequency of allelic imbalance at regions of chromosome arm 8p in ovarian carcinoma. Cancer Genet. Cytogenet. 129 (2001) 23-29
42. Rappold I., Iwabuchi K., Date T., and Chen J. Tumor suppressor p53 binding protein 1 (53BP1) is involved in DNA damage-signaling pathways. J. Cell Biol. 153 (2001) 613-620
43. Rouse J., and Jackson S.P. Interfaces between the detection, signaling and repair of DNA damage. Science 297 (2002) 547-551
44. Sancar A., Lindsey-Boltz L.A., Unsal-Kacmaz K., and Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu. Rev. Biochem. 73 (2004) 39-85
45. Scully R., Chen J., Ochs R.L., Keegan K., Hoekstra M., Feunteun J., and Livingston D.M. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 90 (1997) 425-435
46. Shao J., Wang H., Huang X., Feng Q., Huang P., Feng B., Huang L., Yu X., Li J., Hu L., et al. Genome-wide allelotype analysis of sporadic primary nasopharyngeal carcinoma from southern China. Int. J. Oncol. 17 (2000) 1267-1275
47. Shen S.X., Weaver Z., Xu X., Li C., Weinstein M., Chen L., Guan X.Y., Ried T., and Deng C.X. Targeted disruption of the murine Brca1 gene causes gamma-irradiation hypersensitivity and genetic instability. Oncogene 17 (1998) 3115-3124
48. Shiloh Y. ATM and ATR: networking cellular responses to DNA damage. Curr. Opin. Genet. Dev. 11 (2001) 71-77
49. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat. Rev. Cancer 3 (2003) 155-168
50. Snijders A.M., Nowak N., Segraves R., Blackwood S., Brown N., Conroy J., Hamilton G., Hindle A.K., Huey B., Kimura K., et al. Assembly of microarrays for genome-wide measurement of DNA copy number. Nat Genet. 29 (2001) 263-264
51. Stewart G.S., Wang B., Bignell C.R., Taylor A.M., and Elledge S.J. MDC1 is a mediator of the mammalian DNA damage checkpoint. Nature 421 (2003) 961-966
52. Stiff T., O'Driscoll M., Rief N., Iwabuchi K., Lobrich M., and Jeggo P.A. ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation. Cancer Res. 64 (2004) 2390-2396
53. Thompson L.H., and Limoli C.L. Recognition, signaling and repair of DNA double-strand breaks in mammalian cells. In: Caldecott K.W. (Ed). Eukaryotic DNA Damage Surveillance and Repair (2003), Origin Kluwer Academic/Plenum Publishers, New York 107-145
54. Thor A., Eng C., Devries S., Paterakos M., Watkin W., Edgerton S., Moore II D., Etzell J., and Waldman F. Invasive micropapillary carcinoma of the breast is associated with chromosome 8 abnormalities detected by comparative genomic hybridization. Hum. Pathol. 33 (2002) 628-631
55. Tutt A., and Ashworth A. The relationship between the roles of BRCA genes in DNA repair and cancer predisposition. Trends Mol. Med. 8 (2002) 571-576
56. Unsal-Kacmaz K., Makhov A.M., Griffith J.D., and Sancar A. Preferential binding of ATR protein to UV-damaged DNA. Proc. Natl. Acad. Sci. USA 99 (2002) 6673-6678
57. van den Bosch M., Bree R.T., and Lowndes N.F. The MRN complex: coordinating and mediating the response to broken chromosomes. EMBO Rep. 4 (2003) 844-849
58. van't Veer L.J., Dai H., van de Vijver M.J., He Y.D., Hart A.A., Mao M., Peterse H.L., van der Kooy K., Marton M.J., Witteveen A.T., et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415 (2002) 530-536
59. Veltman J., Fridlyand J., Pejavar S., Olshen A., Korkola J., DeVries S., Carroll P., Kuo W., Pinkel D., Albertson D., et al. Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. Cancer Res. 63 (2003) 2872-2880
60. Wang B., Matsuoka S., Carpenter P., and Elledge S.J. 53BP1, a mediator of the DNA damage checkpoint. Science 298 (2002) 1435-1438
61. Wang X., Zou L., Zheng H., Wei Q., Elledge S.J., and Li L. Genomic instability and endoreduplication triggered by RAD17 deletion. Genes Dev. 17 (2003) 965-970
62. Wang Y., Putnam C.D., Kane M.F., Zhang W., Edelmann L., Russell R., Carrion D.V., Chin L., Kucherlapati R., Kolodner R.D., and Edelmann W. Mutation in Rpa1 results in defective DNA double-strand break repair, chromosomal instability and cancer in mice. Nat. Genet. 37 (2005) 750-755
63. Wang Y., Klijn J.G., Zhang Y., Sieuwerts A.M., Look M.P., Yang F., Talantov D., Timmermans M., Meijer-van Gelder M.E., Yu J., et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365 (2005) 671-679
64. Ward I.M., Minn K., van Deursen J., and Chen J. P53 binding protein 53BP1 is required for DNA damage responses and tumor suppression in mice. Mol. Cell. Biol. 23 (2003) 2556-2563
65. Xu X., and Stern D.F. NFBD1/MDC1 regulates ionizing radiation-induced Focus formation by DNA checkpoint signaling and repair factors. FASEB J. 17 (2003) 1842-1848
66. Xu X., Lee J., and Stern D.F. Microcephalin is a DNA damage response protein involved in regulation of CHK1 and BRCA1. J. Biol. Chem. 279 (2004) 34091-34094
67. Yu X., Chini C., He M., Mer G., and Chen J. The BRCT domain is a phospho-protein binding domain. Science 302 (2003) 639-642
68. Zhang Y., Lim C.U., Williams E.S., Zhou J., Zhang Q., Fox M.H., Bailey S.M., and Liber H.L. NBS1 knockdown by small interfering RNA increases ionizing radiation mutagenesis and telomere association in human cells. Cancer Res. 65 (2005) 5544-5553
69. Zhong Q., Chen C.F., Li S., Chen Y., Wang C.C., Xiao J., Chen P.L., Sharp Z.D., and Lee W.H. Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response. Science 285 (1999) 747-750
70. Zhou B.B., and Elledge S.J. The DNA damage response: putting checkpoints in perspective. Nature 408 (2000) 433-439
71. Zou L., and Elledge S.J. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science 300 (2003) 1542-1548
72. Zou L., Cortez D., and Elledge S.J. Regulation of ATR susbstrate selection by Rad17-dependent loading of Rad9 complexes on to chromatin. Genes Dev. 16 (2002) 198-208
73. Zou L., Liu D., and Elledge S.J. Replication protein A-mediated recruitment and activation of Rad17 complexes. Proc. Natl. Acad. Sci. USA 100 (2003) 13827-13832